PRESS RELEASE: Global Music Publishing Market Research Report

The global Music Publishing Market research report studies market overview defining; definition, types, applications latest trends to identify the revenues and the progress of the market over the forecast period. The report offers preventive and premeditated management along with emphasizes the summary of the global Music Publishing market along with classifications and market chain structures. It also highlights authorized statistics of the global Music Publishing market.

Get a Sample PDF Report: https://www.acquiremarketresearch.com/sample-request/113470/

Improvement approaches and plans are examined just as assembling procedures and cost structures are additionally investigated. This report likewise states import/trade utilization, free market activity Figures, cost, value, income and gross edges. The report centers around Global real driving Music Publishing Industry players giving data, for example, organization profiles, item picture and determination, limit, generation, value, cost, income and contact data.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows: Major-Type, Independent-Type, Administrator-Type

Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows: Sony Music Publishing LLC, Universal Music Publishing Group, Warner Music, Fox Music Publishing, Super Cassettes Industries Private Ltd, Kobalt Music Group, Broadcast Music, Disney Music, Avatar Publishing, MPL Communications

Based on Application, the report describes major application share of regional market. Application mentioned as follows: Commercial, Commonweal, Others

Music Publishing Market
The fundamental purpose of this Music Publishing market report is to provide a correct and strategic analysis of the Profile Projectors industry. The report scrutinizes each segment and sub-segments presents before you a 360-degree view of the said market.It provides a deep insight into the industry parameters by accessing the market growth, consumption volume, the upcoming market trends, and the different prices variation for the forecast year.

The research methodology of the market involves both primary as well as secondary research data sources. It commits different factors affecting Music Publishing industry such as market environment, various policies of the government, past data and market trends, technological advancements, upcoming innovations, market risk factors, market restraints, and challenges in the industry.

Get Discount on this Report: https://www.acquiremarketresearch.com/discount-request/113470/

The report grants knowledge on the accompanying pointers:

– Market Penetration: Comprehensive data on the items collection of the top players in the Music Publishing market.

– Product Development/Innovation: Detailed knowledge on the forthcoming advances, R&D actions, and product dispatches in the Music Publishing market

– Competitive Assessment: top to bottom appraisal of the market systems, geographic and business sections of the main players in the Music Publishing market

– Market Development: Comprehensive data about developing markets. This report breaks down the market for a different area overall topographies

– Market Diversification: Exhaustive data about new items, undiscovered topographies, late advancements, and capital exposures in the Music Publishing market

With tables and figures broken down on worldwide Global Music Publishing market, this research gives key measurements on the condition of the business and is a profitable wellspring in direction and course for organizations and people intrigued by the market.

For compiling the report, data has been derived from a number of paid and unpaid sources such as presentations, white papers, journals, and press releases. It offers in-depth information obtained through extensive primary and secondary research methods. The information has been further assessed using various effective analytical tools. Therefore, the report provides a 360-degree view of market.

Read Complete Report With TOC: https://www.acquiremarketresearch.com/industry-reports/music-publishing-market/113470/

At last, It includes the methodical description of the various factors such as the Music Publishing market growth and a detailed information about the different company’s revenue, growth, technological developments, production and the various other strategic developments.

PRESS RELEASE: Best SEO Company in United States – 1st Page of Google Guaranteed

SEO Services United States – Internet Marketing – SEM – Social Media – PPC – Website Development – Website Optimization

Hand submitted citations and no outsourcing to foreign companies – Best SEO company in United States – 1st Page of Google Guaranteed.

RIVERSIDE, CALIFORNIA, UNITED STATES, January 9, 2018 /– SEO – SEM – Website Optimization – Website Development – Internet Marketing & Citation Building United States

Best SEO & Internet Marketing Company from Los Angeles, California. No outsourcing to foreign countries. 1st Page of Google guaranteed.

Sevilla Local Media is a U.S. based Digital Marketing Company offering: SEO Services + Website Optimization + Google Maps Optimization + Social Media Marketing + Website Development + Video Optimization + PPC Management + Reputation Management + Local Business Directories + Internet Leads Generation at an affordable price with performance guarantees!

SEO Services Riverside, Los Angeles, Fresno United States

Tommy Sevilla
Sevilla Local Media
(951) 289-1710


grace for the cure

PRESS RELEASE: Type 1 diabetes and the developing brain in children

SAN FRANCISCO (June 10, 2019) – A study co-led by Dr. Nelly Mauras at Nemours Children’s Health System in Jacksonville, Florida found that children with type 1 diabetes (T1D) have slower growth in brain areas associated with mild cognitive deficits compared to children without T1D. The study, presented today at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions®, found significant differences in total brain and regional gray and white matter growth based on a series of three structural magnetic resonance imaging (MRI) studies.

“Even with new insulin and technologies that can significantly improve care, children with Type 1 Diabetes are still exposed to significant swings in sugar control, creating potential risks to the developing brain,” said Nelly Mauras, MD, co-principal investigator of the study, chief of the division of endocrinology, diabetes & metabolism at the Nemours Children’s Health System in Jacksonville, Florida, and professor of pediatrics at the Mayo College of Medicine. “Understanding the early effects of blood sugar control on brain development is a necessary step towards developing strategies for reducing these risks and the public health implications of diabetes-related cognitive dysfunction later on in life.”

As part of a multi-site study of the Diabetes Research in Children Network (DirecNet), researchers aimed to determine the extent to which glycemic exposure adversely impacts the developing brain in children with early-onset T1D. The study enrolled 138 children with T1D with a median age of seven years. The participants had a disease duration on average of 2.4 years at the beginning of the study. MRIs were performed at three time points (baseline visit, 18 months and approximately 2.9 years after the second visit) to measure gray and white matter volumes in key brain regions. Total cumulative hyperglycemic exposure was determined using lifetime blood sugar, using hemoglobin A1c (HbA1c) values from the time of diagnosis. Researchers compared the MRI results of T1D participants to those of a control group of 66 age-matched children who did not have diabetes.

Researchers found that the group with T1D had slower growth of total cortical and subcortical gray and white matter than the control group at all time points. In particular, a set of metabolically active brain regions associated with other brain disorders, known as the “default mode network,” showed less growth in the T1D group compared to the control group. These regions of slower growth were associated with higher lifetime blood sugar, as measured by HbA1c values.

“Ongoing research is investigating whether diligent maintenance of blood sugar levels in the normal range through advanced diabetes technologies can impact these findings to reduce the risk for cognitive dysfunction,” said Mauras.


The DirecNet includes Nemours Children’s Health System JAX, Stanford University, University of Iowa, Washington University in St Louis, and Yale University. The research is supported through funding from the National Institutes of Health’s Special Type 1 Diabetes Funds and the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Dr. Mauras and her co-principal investigator, Allan Reiss, MD, Howard C. Robbins Professor of Psychiatry and Behavioral Sciences and Professor of Radiology at Stanford University School of Medicine, will present these findings in a press briefing on Sunday, June 9, 2019 from 12-1 p.m. PT at the American Diabetes Association’s 79th Scientific Sessions in San Francisco.

About Nemours Children’s Health System

Nemours is an internationally recognized children’s health system that owns and two free-standing children’s hospitals: the Nemours/Alfred I. duPont Hospital for Children in Wilmington, Del., and Nemours Children’s Hospital in Orlando, Fla., along with outpatient facilities in five states, delivering pediatric primary, specialty and urgent care. Nemours also powers the world’s most-visited website for information on the health of children and teens, KidsHealth.org, and offers on-demand, online video patient visits through Nemours CareConnect. Nemours ReadingBrightstart.org is a program dedicated to preventing reading failure in young children, grounded in Nemours’ understanding that child health and learning are inextricably linked, and that reading level is a strong predictor of adult health.

Established as The Nemours Foundation through the legacy and philanthropy of Alfred I. duPont, Nemours provides pediatric clinical care, research, education, advocacy and prevention programs to families in the communities it serves.

consumer news logo

CFPB To Hold First Symposium On June 25

June 11, 2019

Office of Communications
Tel: (202) 435-7170

CFPB To Hold First Symposium On June 25

WASHINGTON, D.C. – The Consumer Financial Protection Bureau announced today that its first symposium will be held on June 25 at 9 a.m. The symposium, part of a series announced earlier this year, will focus on the Dodd-Frank Act’s prohibition on abusive acts or practices. The symposium will be webcast on the Bureau’s website.

The Dodd-Frank Act authorizes the Bureau to take enforcement, supervision, and rulemaking actions concerning unfair, deceptive, or abusive acts and practices (UDAAP). The meaning of abusiveness is less developed than the meaning of unfair or deceptive, which have been defined substantially by the Federal Trade Commission Act. The symposium will provide a public forum for the Bureau and the public to hear various perspectives on the meaning of abusiveness.

This first symposium will have two panels of UDAAP experts. The symposium will also include remarks by CFPB Director Kathleen L. Kraninger and CFPB Deputy Director Brian Johnson. The first panel will include a discussion with leading academic experts in the area of Consumer Protection on various policy issues relating to the abusive standard under Dodd-Frank. The panel will be moderated by Tom Pahl, CFPB’s Policy Associate Director, Research, Markets and Regulation. The experts on the panel will include:

• Patricia McCoy, Professor of Law, Boston College Law School
• Todd Zywicki, Professor of Law, George Mason University, Antonin Scalia Law School
• Howard Beales, George Washington University; former Director of the Federal Trade Commission (FTC) Bureau of Consumer Protection
• Adam Levitin, Professor of Law, Georgetown Law School

The second panel will examine how the abusive standard has been used in practice, and will include leading legal experts in the field. The panel will be moderated by David Bleicken, CFPB Deputy Associate Director, Supervision, Enforcement and Fair Lending. Experts on the panel will include:
• William MacLeod, Partner at Kelley Drye; former Director of the FTC Bureau of Consumer Protection and Bureau of Competition
• Eric Mogilnicki, Partner at Covington & Burling; former Chief of Staff, Senator Ted Kennedy
• Lucy Morris, Partner Hudson Cook; former CFPB Deputy Enforcement Director
• Nicholas Smyth, Assistant Director of the Pennsylvania Office of Attorney General’s Bureau of Consumer Protection, Senior Deputy Attorney General

Members of the public that plan to attend the symposium should RSVP at: https://consumer-financial-protection-bureau.forms.fm/cfpb-symposium-on-unfair-deceptive-or-abusive-acts-or-practices-udaap-2

The Consumer Financial Protection Bureau is a 21st century agency that helps consumer finance markets work by regularly identifying and addressing outdated, unnecessary, or unduly burdensome regulations, by making rules more effective, by consistently enforcing federal consumer financial law, and by empowering consumers to take more control over their economic lives. For more information, visit consumerfinance.gov.

AWS Announces General Availability of Amazon Personalize

AWS Announces General Availability of Amazon Personalize
June 10, 2019 at 6:07 PM EDT


Amazon Personalize enables developers to build applications with the same machine learning technology used by Amazon.com for real-time personalized recommendations – with no machine learning expertise required

Yamaha, Subway, and Zola among customers using Amazon Personalize

SEATTLE–(BUSINESS WIRE)–Jun. 10, 2019– Today, Amazon Web Services, Inc. (AWS), an Amazon.com company (NASDAQ: AMZN), announced the general availability of Amazon Personalize, bringing the same machine learning technology used by Amazon.com to AWS customers for use in their applications – with no machine learning experience required. Amazon Personalize makes it easy to develop applications with a wide array of personalization use cases, including specific product recommendations, individualized search results, and customized direct marketing. Amazon Personalize is a fully managed service that trains, tunes, and deploys custom, private machine learning models. Amazon Personalize provisions the necessary infrastructure and manages the entire machine learning pipeline, including processing the data, identifying features, selecting algorithms, and training, optimizing, and hosting the results. Customers receive results via an Application Programming Interface (API) and only pay for what they use, with no minimum fees or upfront commitments. To get started with Amazon Personalize, visit https://aws.amazon.com/personalize/

Amazon has pioneered the use of machine learning for recommendation and personalization for more than 20 years. During that time, customers have asked for access to these capabilities so they could enjoy similar benefits when running their businesses. However, the technology can be challenging to deliver effectively across a variety of use cases because there isn’t a single, master personalization algorithm. Each use case – videos, music, products, or news articles – has its own specificities, which requires a unique mix of data, algorithms, and optimizations to create a result. Today’s general availability of Amazon Personalize provides a major step toward putting the power of Amazon’s experience in machine learning into the hands of everyday application developers and data scientists at businesses of all sizes across all industries. Amazon Personalize reduces the time to build a custom model from months to days. When using Amazon Personalize, customers provide the service an activity stream from an application (e.g. page views, signups, or purchases) along with an inventory of the items to recommend (e.g. music, videos, products, or news articles), and receive recommendations via an API. Amazon Personalize does this by processing and examining the data, identifying what is meaningful, selecting from multiple advanced algorithms built and refined over years for Amazon’s retail business, and training and optimizing a personalization model customized to the data. During the whole time, all of the data is kept completely private, owned entirely by the customer.

“We are excited to share with AWS customers the expertise we’ve developed during two decades of using machine learning to deliver great experiences on Amazon.com,” said Swami Sivasubramanian, Vice President of Machine Learning, Amazon Web Services, Inc. “Customers have been asking for Amazon Personalize, and we are eager to see how they implement these services to delight their own end users. And the best part is that these artificial intelligence services, like Amazon Personalize, do not require any machine learning experience to immediately train, tune, and deploy models to meet their business demands.”

Amazon Personalize is available today in US East (Ohio), US East (N. Virginia), US West (Oregon), Asia Pacific (Tokyo), Asia Pacific (Singapore) and EU (Ireland) with additional regions coming soon.

Yamaha Corporation of America (YCA) offers a large assortment of high-quality musical instruments and audio products to U.S. customers. Their products include Keyboard, Guitar, Winds and Strings, Percussion, Professional Audio and Consumer Audio. “Amazon Personalize saves us up to 60% of the time needed to set up and tune the infrastructure and algorithms for our machine learning models when compared to building and configuring the environment on our own. It is ideal for both small developer teams who are trying to build the case for ML and large teams who are trying to iterate rapidly at reasonable cost. Even better, we expect Amazon Personalize to be more accurate than other recommender systems, allowing us to delight our customers with highly personalized product suggestions during their shopping experience, which we believe will increase our average order value and the total number of orders,” said Ishwar Bharbhari, Director of Information Technology, Yamaha Corporation of America.

The Subway restaurant chain offers guests in over 100 countries quality ingredients and flavor combinations with nearly 7 million made-to-order sandwiches created daily. “At Subway, guest experience matters,” said Neville Hamilton, Interim Chief Information Officer at Subway. “Using Amazon Personalize, we can quickly deliver personalized recommendations for our endless varieties of ingredients and flavors to fit the unique lifestyles of our busy guests. Amazon Personalize lets our team use simple API calls to curate recommendations without requiring machine learning expertise. We are looking forward to continuing to work with Amazon Personalize to provide the best experience to our guests who want to eat fresh. We have already successfully tested using Amazon Personalize to provide recommendations to guests making orders from our app, and are excited to expand into personalized app notifications in the near future.”

Zola is the fastest-growing wedding company in the country using design and technology to create the easiest wedding planning and registry experience for couples. “At Zola, we develop innovative wedding planning tools. We want to be there along the entire wedding journey and provide the best possible recommendations to our customers based on their style, interests, or preferences. Until now, those recommendations have been implemented via rule-based ranking, popularity, or more recently, via a similarity model calculated internally. These methods were difficult to maintain and scale. Amazon Personalize provides us with state-of-the-art algorithms and an end-to-end personalization solution that enables us to provide recommendations and personalized content in real time. Being a small team, using Amazon Personalize will allow us to quickly deliver capabilities that would have otherwise taken a much larger team and several months development time,” said Stephane Bailliez, Vice President of Engineering at Zola.

Segment provides customer data infrastructure allowing companies to collect, unify, and connect their first-party customer data to over 200 marketing, analytics, and data warehousing tools with just a flip of a switch. “Today’s consumers expect real-time personalization and recommendations, yet the reality for most companies is that the amount of engineering required makes that experience very hard to create, let alone deliver,” said Tom Pinckney, Head of Partnerships at Segment. “Amazon Personalize brings Amazon’s world-class machine learning technology to every company. By combining it with Segment’s Customer Data Infrastructure, our customers can deliver these highly individualized recommendations at scale and in real time. We have been impressed and plan to extend its functionality for Segment with further integration in the future.”

About Amazon Web Services

For almost 13 years, Amazon Web Services has been the world’s most comprehensive and broadly adopted cloud platform. AWS offers over 165 fully featured services for compute, storage, databases, networking, analytics, robotics, machine learning and artificial intelligence (AI), Internet of Things (IoT), mobile, security, hybrid, virtual and augmented reality (VR and AR), media, and application development, deployment, and management from 66 Availability Zones (AZs) within 21 geographic regions, spanning the U.S., Australia, Brazil, Canada, China, France, Germany, Hong Kong Special Administrative Region, India, Ireland, Japan, Korea, Singapore, Sweden, and the UK. Millions of customers including the fastest-growing startups, largest enterprises, and leading government agencies—trust AWS to power their infrastructure, become more agile, and lower costs. To learn more about AWS, visit aws.amazon.com.

About Amazon

Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. Customer reviews, 1-Click shopping, personalized recommendations, Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing, Kindle, Fire tablets, Fire TV, Amazon Echo, and Alexa are some of the products and services pioneered by Amazon. For more information, visit amazon.com/about and follow @AmazonNews.

Russian authorities have dropped all charges against Russian journalist Ivan Golunov


(NEW YORK)– In response to the news that Russian authorities have dropped all charges against Russian journalist Ivan Golunov, PEN America issued the following statement:

“The dropping of all charges against Ivan Golunov is cause for celebration, both because it means this dogged reporter is free to return to his work, and also because it reminds us that even an intransigent government can be moved by international outcry. We all know well that Golunov could easily have ended up spending years in prison as a result of these spurious charges, but the solidarity shown by journalists and newspapers in Russia and the voices from across the globe denouncing Golunov’s arrest helped stave off this injustice. The Russian government should know that the world will not look away from its attempts to silence truth-tellers.”

CONTACT: PEN America media consultant Suzanne Trimel, strimel@pen.org

South Carolina Man Sentenced for Attempting to Provide Material Support to ISIS

Department of Justice
Office of Public Affairs

Tuesday, June 11, 2019

South Carolina Man Sentenced for Attempting to Provide Material Support to ISIS

Zakaryia Abdin, 20, of Ladson, South Carolina, was sentenced yesterday to 20 years to be followed by a lifetime of supervised release for attempting to provide material support to the Islamic State of Iraq and al-Sham (ISIS), a designated foreign terrorist organization.  Abdin previously entered a guilty plea in August of 2018 and has remained in federal custody since his arrest by the FBI in March of 2017.

Assistant Attorney General for National Security John C. Demers, U.S. Attorney Sherri A. Lydon for the District of South Carolina and Special Agent in Charge Jody Norris of the FBI’s Columbia Division made the announcement.  Abdin appeared before U.S. District Court Judge Richard M. Gergel.

“The Department of Justice is committed to holding accountable U.S. citizens, like Abdin, and others who would leave here to provide material support to ISIS overseas,” said Assistant Attorney General Demers.  “Thanks to the great work of the agents and prosecutors on this case, his plans were thwarted and with this sentence he is now being held accountable for his crime.  The National Security Division is committed to identifying and bringing to justice those who would provide material support to foreign terrorist organizations.”

“The most important job of government is protecting the people of the United States from harm, whether it comes from criminals or terrorists,” said U.S. Attorney Lydon.  “This case is an example of law enforcement doing exactly that, and preventing what could have been a much greater tragedy.  I am proud of the great work JTTF did in preventing this defendant from joining ISIS and fighting on their behalf, whether that would have been domestically or internationally.  His goal was to kill on behalf of ISIS, whether that was in the United States or abroad.  His goal was to be an ISIS soldier, and to kill Americans wherever ISIS directed him.”  U.S. Attorney Lydon commended the intense work of Charleston’s Joint Terrorism Task Force and noted that this is the first conviction for a person attempting to provide material support to a terrorist organization in the District of South Carolina.

“Once again, the Joint Terrorism Task Force has uncovered, investigated and prevented terrorist activity with roots in South Carolina” said Special Agent in Charge Norris.  “These results are made possible by the coordinated efforts of our federal, state and local partners, who are committed to sharing information and resources to protect our communities.”

The FBI arrested the defendant at the Charleston International Airport on March 30, 2017, when he attempted to board an airplane in order to travel overseas to join ISIS.

According to court documents, Abdin, a U.S. citizen, began his efforts on Jan. 3, 2017, when he created a social media account to be used to join ISIS.   On Jan. 20, 2017, Abdin visited the FBI in Mount Pleasant, South Carolina, to meet with an FBI Special Agent from the Joint Terrorism Task Force.  During this visit, the agent advised Abdin about the FBI’s role in conducting counterterrorism investigations, discussed various statutory definitions (including terrorism), and told Abdin that ISIS was a designated foreign terrorist organization and that it was illegal to give any foreign terrorist organization any form of material support, including personnel.

After that date, Abdin began to seek a handler to get him overseas to Syria or Egypt to make contact with ISIS.  Unbeknownst to him, he ended up making contact with an undercover FBI employee.  Abdin believed this person was affiliated with ISIS.  These communications continued up until he was arrested.

Abdin had extensive communications with the undercover FBI employee.  During the course of these on line conversations, Abdin expressed continued loyalty to ISIS.  He said he had given a pledge of loyalty to ISIS in 2014 and provided a video of a new pledge to Abu Baker al Baghdadi, the self-proclaimed leader of ISIS, in which Abdin pledged to “wage jihad against the enemy of Allah.”

Abdin also indicated that he wished to join ISIS and its so-called caliphate and requested to serve in combat.  He stated that he was proficient with various weapons, including pistols and AK and SKS rifles.  He also asserted that he was well prepared, knew how to shoot, and had experience with and was reliable in close combat.  He also purchased weapons, including an SKS assault rifle, modifying it to expand its capacity from a 10 round magazine to a 30 round magazine.  Abdin practiced with an AK assault rifle at a local gun store, and with an SKS assault rifle and a 9mm handgun at a local outdoor shooting range outside of Charleston.

Abdin took a picture of himself carrying the 9mm in his waistband and took a picture of himself practicing shooting at night at the local outdoor range, and sent these to the undercover FBI employee.

Abdin undertook concrete steps to join ISIS and travel overseas to fight jihad.  He applied for a passport.  On March 22, 2017, the FBI was notified Abdin’s passport was delivered to his residence in Ladson.  Later on the same date, Abdin sent a message to the undercover FBI employee to tell him to “let the brothers know I am coming very soon.”

On March 23, 2017, Abdin made flight reservations aboard a commercial airline departing Charleston with a final destination of Amman, Jordan.  The date for travel was set for March 30, 2017.  After making the reservations, Abdin told to undercover FBI employee that he was scheduled to arrive in Amman, Jordan on April 1, 2017.

On March 30, 2017, Abdin arrived at the Charleston International Airport, checked in for his departing flight, and was subsequently arrested.

Abdin faces a statutory maximum sentence of 20 years in prison.  The maximum statutory sentence is prescribed by Congress and is provided here for informational purposes.  Any sentencing of the defendant will be determined by the court based on the advisory Sentencing Guidelines and other statutory factors.

This case was prosecuted by Assistant U.S. Attorneys Nathan Williams and Sean Kittrell of the District of South Carolina and Trial Attorney Jennifer Burke of the National Security Division’s Counterterrorism Section.

department of justice news

Former Owners of T-Mobile Retail Store Arrested on Federal Charges Alleging $25 Million Scheme to Illicitly Unlock Cell Phones

Department of Justice
U.S. Attorney’s Office
Central District of California

Monday, June 10, 2019

Former Owners of T-Mobile Retail Store Arrested on Federal Charges Alleging $25 Million Scheme to Illicitly Unlock Cell Phones

          LOS ANGELES – Two men who formerly owned a T-Mobile retail store in Eagle Rock were arrested this morning on federal charges that allege a scheme to use stolen T-Mobile employee credentials to illegally infiltrate the mobile phone company’s internal computer systems to “unlock” cell phones so they could be used on any carrier’s network. The defendants were arrested pursuant to a 21-count grand jury indictment outlining the scheme that investigators believe earned the two men more than $25 million.

Argishti Khudaverdyan, 41, of Burbank, and Alen Gharehbagloo, 40, of La Cañada Flintridge, are charged with multiple felonies, including conspiracy to commit wire fraud, wire fraud, bank fraud, computer fraud and money laundering. The indictment also seeks the forfeiture of more than $2.25 million seized from several bank accounts and residential properties allegedly purchased with ill-gotten gains.

Khudaverdyan and Gharehbagloo are expected to be arraigned on the indictment this afternoon in United States District Court in downtown Los Angeles.

According to the indictment, for the first six months of 2017, Khudaverdyan and Gharehbagloo were co-owners of Top Tier Solutions, Inc., a T-Mobile premium retail store in the Eagle Rock Plaza in Northeastern Los Angeles. During this time, most cellular phone companies – including T-Mobile – “locked” their customers’ phones so they could be used only on the company’s network until the customers’ phone-purchase and service contracts had been fulfilled. If customers wanted to switch to a different carrier, their phones had to be “unlocked.”

Khudaverdyan and Gharehbagloo allegedly conspired to fraudulently unlock T-Mobile phones, which would allow T-Mobile customers to stop using T-Mobile’s services and thereby deprive T-Mobile of revenue generated from customers’ service contracts and equipment installment plans. The defendants also allegedly conspired to “whitelist” or “clean” phones that had been reported lost or stolen so they could be activated again.

Between August 2014 and January 2019, Khudaverdyan and Gharehbagloo allegedly advertised their unlocking services through brokers, email solicitations and websites such as unlocks247.com. The defendants falsely claimed they provided “official” T-Mobile unlocks.

In order to gain unauthorized access to T-Mobile’s protected internal computers, Khudaverdyan obtained T-Mobile employees’ credentials through various means, including phishing emails that appeared to be legitimate T-Mobile correspondence. The fraudulent emails were used by Khudaverdyan to deceive T-Mobile employees to log in with their employee credentials so that Khudaverdyan could harvest the employees’ information and fraudulently unlock the phones, according to the indictment. Khudaverdyan and Gharehbagloo, assisted by a co-conspirator, allegedly used the Wi-Fi access points inside T-Mobile Stores to log onto the company’s internal network using compromised employee credentials.

Investigators have determined that Khudaverdyan and Gharehbagloo obtained more than $25 million for these illicit activities. They allegedly used these illegal proceeds to pay for, among other things, real properties in Burbank, Northridge and La Cañada Flintridge.

The indictment in this case was returned by a federal grand jury on June 6 and unsealed today.

An indictment contains allegations that a defendant has committed a crime. Every defendant is presumed innocent until and unless proven guilty beyond a reasonable doubt.

If Khudaverdyan is convicted of all 17 counts in which he is charged, he would face a statutory maximum of 237 years in federal prison. If convicted of all 15 counts with which he is charged, Gharehbagloo would face a statutory maximum of 235 years in federal prison.

This matter is being investigated by the United States Secret Service Electronic Crimes Task Force (ECTF) in Los Angeles and IRS Criminal Investigation’s Western Area Cyber Crime Unit. The ECTF includes representatives of the Secret Service, the Federal Bureau of Investigation, the Los Angeles Police Department, the Los Angeles District Attorney’s Office, and the California Highway Patrol.

This case is being prosecuted by Assistant United States Attorney Jennie L. Wang of the Cyber and Intellectual Property Crimes Section and Special Assistant United States Attorney Ryan Waters of the Asset Forfeiture Section.

department of justice news

Former Colorado Springs Sheriff’s Deputy Sentenced to Nine Years in Prison for Receiving and Possessing Child Pornography

Department of Justice
U.S. Attorney’s Office
Southern District of Florida

Monday, June 10, 2019

Former Colorado Springs Sheriff’s Deputy Sentenced to Nine Years in Prison for Receiving and Possessing Child Pornography

Donald Glenn Beasley (“Beasley”), 56, of Key Largo, was sentenced today by U.S. District Court Judge K. Michael Moore to 108 months in prison and 20 years of supervised release for receiving and possessing child pornography in connection with internet downloads Beasley made of child pornography.

Ariana Fajardo Orshan, U.S. Attorney for the Southern District of Florida and George Piro, Special Agent in Charge, Federal Bureau of Investigations (FBI), Miami Field Office, made the announcement.

Beasley, a former sheriff’s deputy in Colorado Springs, Colorado, had been downloading child pornography on a peer-to-peer network and utilizing a state of the art encryption when he became known to FBI special agents. According to the stipulated facts filed in court, on September 20, 2018, a search warrant was executed at Beasley’s residence located at 95500 Overseas Highway in Key Largo, Florida. Pursuant to the search warrant, law enforcement searched a Starcraft trailer, which records checks revealed was registered to Beasley.

After a search of the Starcraft trailer, law enforcement seized various electronic items, including Beasley’s laptop and 3 external hard drives. The forensic examination of the items revealed multiple videos and numerous images of child pornography, many involving minor children under the age of 12. On February 11, 2019, Beasley pled guilty to the receipt and possession of child pornography.

U.S. Attorney Fajardo Orshan commended the investigatory efforts of the FBI in this matter.  She thanked the National Center for Missing and Exploited Children for their assistance.  This case was prosecuted by Assistant U.S. Attorney Alejandra L. López. 

This case was brought as part of Project Safe Childhood, a nationwide initiative to combat the growing epidemic of child exploitation and abuse launched in May 2006 by the Department of Justice. Led by U.S. Attorney’s Offices and the Criminal Division’s Child Exploitation and Obscenity Section, Project Safe Childhood marshals federal, state and local resources to better locate, apprehend and prosecute individuals who exploit children via the Internet, as well as to identify and rescue victims. For more information about Project Safe Childhood, please visit www.projectsafechildhood.gov.

Related court documents and information may be found on the website of the District Court for the Southern District of Florida at www.flsd.uscourts.gov or on https://pacer.flsd.uscourts.gov.

department of justice news

Former pro baseball player sentenced to federal prison in Operation Vanilla Gorilla

Department of Justice
U.S. Attorney’s Office
Southern District of Georgia

Monday, June 10, 2019

Former pro baseball player sentenced to federal prison in Operation Vanilla Gorilla

DJ Driggers admitted meth trafficking, firearms possession

SAVANNAH, GA: A former professional baseball player has been sentenced to nearly five years in federal prison for his role in a drug trafficking network dismantled in Operation Vanilla Gorilla.

Darren J. Driggers, also known as “DJ” and “eBay,” 26, of Bloomingdale, Ga., was sentenced to 57 months in prison by U.S. District Judge R. Stan Baker for Conspiracy to Possess with Intent to Distribute and to Distribute Controlled Substances and for possession of a firearm by a convicted felon, said Bobby L. Christine, U.S. Attorney for the Southern District of Georgia.

At the completion of his incarceration, Driggers will be on supervised release for three years. There is no parole in the federal system. Because he was on probation when he committed his offense, his federal sentence will be served consecutively to his sentence for violating probation.

In November 2018, a federal grand jury indicted Driggers and 42 other defendants as part of Operation Vanilla Gorilla, an Organized Crime Drug Enforcement Task Forces (OCDETF) investigation into a drug trafficking organization associated with the Ghost Face Gangsters, a violent criminal street gang. Of the 43 defendants, 41 have been convicted of federal charges in this multi-district case.

According to information presented in court filings and testimony, Driggers and other conspirators, including associates of the Ghost Face Gangsters, distributed crystal methamphetamine throughout southern Georgia. Driggers, a convicted felon, also possessed and sold stolen firearms to conspirators to assist the drug trafficking organization by promoting a climate of fear. During the investigation, Driggers bragged to federal agents that he was nicknamed “eBay” because he sold stolen goods via social media platforms.

Prior to his criminal activity, Driggers was selected in June 2012 in the 22nd round of the Major League Baseball draft by the Detroit Tigers. The following year he received a 50-game suspension after failing a drug test, and in January 2014 he was released from the MLB after positive drug screens. Driggers explained to the United States Probation Office that “I decided I liked meth better than baseball.”

“DJ Driggers was a gifted athlete who did what thousands of hard-working athletes can only dream about: He was chosen to play professional sports,” said Bobby L. Christine, U.S. Attorney for the Southern District of Georgia. “Instead, he fouled out of his once-promising career by abusing illegal drugs, squandering a truly major-league opportunity and will now spend half a decade in prison for gun and drug charges.”

“This is yet another example of the law enforcement community working together to make our streets and communities a safer place to live, said Beau Kolodka, Assistant Special Agent in Charge of the Atlanta Field Division of the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF). “Dismantling these violent drug trafficking networks continues to be a priority for ATF and our law enforcement partners.”

“Methamphetamine continues to dominate the country as the most abused illicit drug,” said Jamie Jones, Special Agent in Charge of the Savannah Office of the Georgia Bureau of Investigation (GBI). “Driggers is just one of many victims whose lives have been destroyed because of meth. However, Driggers made the decision to become a distributor of this poison, which in turn affected countless others. This was his downfall, as distributors become targets of law enforcement and go to prison or in some cases end up dead in the street. Fortunately for Driggers, he goes to prison and not the graveyard.”

Operation Vanilla Gorilla was investigated under the Organized Crime Drug Enforcement Task Forces (OCDETF), the premier U.S. Department of Justice program to dismantle multi-jurisdictional drug trafficking organizations. The case was investigated by the ATF, the Drug Enforcement Administration (DEA), the GBI, the Chatham County Narcotics Team (CNT), the Georgia Department of Corrections Intelligence Division, the Savannah Police Department, the Chatham County Sheriff’s Office, the Bryan County Sheriff’s Office, the Richmond Hill Police Department, the Pooler Police Department, the Effingham County Sheriff’s Office and the Bloomingdale Police Department, with assistance from the U.S. Marshals Service.

This case was prosecuted by Assistant United States Attorneys E. Greg Gilluly Jr. and Frank Pennington.

department of justice news

Owners of Los Angeles Home Health Agency Sentenced to Prison for Role in Health Care Fraud that Defrauded Medicare

Department of Justice
Office of Public Affairs

Tuesday, June 11, 2019

Owners of Los Angeles Home Health Agency Sentenced to Prison for Role in Health Care Fraud that Defrauded Medicare

Two owners and operators of a Los Angeles, California, home health agency were sentenced to 120 and 78 months in prison yesterday for their roles in a scheme to bill Medicare for various items and services, including home health services, diagnostic testing, medical procedures and durable medical equipment that were not medically necessary and/or were not provided.

Assistant Attorney General Brian A. Benczkowski of the Justice Department’s Criminal Division, U.S. Attorney Nicola T. Hanna of the Central District of California, Special Agent in Charge Christian J. Schrank of the U.S. Department of Health and Human Services Office of Inspector General’s (HHS-OIG) Los Angeles Regional Office, Assistant Director in Charge Paul D. Delacourt of the FBI’s Los Angeles Division and Special Agent in Charge Ryan Korner of the IRS Criminal Investigations’ (IRS-CI) Los Angeles Field Office made the announcement.

Angela Avetisyan, 43, of Glendale, California, was sentenced to 120 months in prison by U.S. District Judge Otis D. Wright II of the Central District of California, who also ordered Avetisyan to pay $4,283,674 in restitution and to forfeit all right, title, and interest in $172,000 seized by the government in May 2014, as well as six real properties purchased with fraud proceeds.  The Court ordered Avetisyan to make an immediate partial restitution payment of $10,000.

Ashot Minasyan, 61, of North Hollywood, California, was sentenced to 78 months in prison by Judge Wright, who also ordered Minasyan to pay $4,283,674 in restitution and to forfeit all right, title, and interest in the same $172,000 and six real properties.  The Court ordered Minasyan to make an immediate partial restitution payment of $100,000.

Avetisyan and Minasyan were charged along with Robert Glazer, 73, and Marina Merino, 62, both of Los Angeles, in a second superseding indictment returned in June 2015.  On June 7, 2019, co-defendants Glazer and Merino were found guilty after a seven day trial of conspiracy to commit health care fraud and health care fraud.

Avetisyan and Minasyan each pleaded guilty on Oct. 9, 2018, to one count of conspiracy to commit health care fraud.  As part of their guilty pleas, Avetisyan and Minasyan admitted that as co-owners and operators of Fifth Avenue Home Health (Fifth Avenue), a home health agency located in Los Angeles, they engaged in a conspiracy with Glazer, Merino and others to recruit Medicare patients to Glazer’s clinic so that Glazer could use those patients’ information to bill for medically unnecessary outpatient clinic services and refer those patients for medically unnecessary home health services from Fifth Avenue and other home health agencies.  Avetisyan and Minasyan further admitted that they paid Merino and other patient recruiters illegal kickbacks to bring Medicare patients to the Glazer clinic.

As found at sentencing by the Court, Avetisyan and Minasyan, along with their co-conspirators, submitted and caused to be submitted false and fraudulent claims for home health services that were medically unnecessary, for services that were not provided and for claims obtained by the payment of illegal kickbacks.

This case was investigated by the HHS-OIG, the FBI and IRS-CI.  Trial Attorneys Claire Yan, Robyn N. Pullio and Emily Z. Culbertson of the Criminal Division’s Fraud Section are prosecuting the case.  The Asset Forfeiture Section of the U.S. Attorney’s Office for the Central District of California is handling the asset forfeiture aspects of the case.

The Fraud Section leads the Medicare Strike Force, which is part of a joint initiative between the Department of Justice and HHS to focus their efforts to prevent and deter fraud and enforce current anti-fraud laws around the country.  Since its inception in March 2007, the Medicare Fraud Strike Force, which maintains 14 strike forces operating in 23 districts, has charged nearly 4,000 defendants who have collectively billed the Medicare program for more than $14 billion.  In addition, the HHS Centers for Medicare & Medicaid Services, working in conjunction with HHS-OIG, are taking steps to increase accountability and decrease the presence of fraudulent providers.

To learn more about the Health Care Fraud Prevention and Enforcement Action Team (HEAT), go to: www.stopmedicarefraud.gov.

department of justice news

Nearly 1,700 Suspected Child Sex Predators Arrested During Operation “Broken Heart”

Department of Justice
Office of Public Affairs

Tuesday, June 11, 2019

Nearly 1,700 Suspected Child Sex Predators Arrested During Operation “Broken Heart”

The Department of Justice today announced the arrest of almost 1,700 suspected online child sex offenders during a two-month, nationwide operation conducted by Internet Crimes Against Children task forces. The task forces identified 308 offenders who either produced child pornography or committed child sexual abuse, and 357 children who suffered recent, ongoing or historical sexual abuse or were exploited in the production of child pornography.

The 61 ICAC task forces, located in all 50 states and comprised of more than 4,500 federal, state, local and tribal law enforcement agencies, led the coordinated operation known as “Broken Heart” during the months of April and May 2019. During the course of the operation, the task forces investigated more than 18,500 complaints of technology-facilitated crimes targeting children and delivered more than 2,150 presentations on internet safety to over 201,000 youth and adults.

“The sexual abuse of children is repugnant, and it victimizes the most innocent and vulnerable of all,” Attorney General William P. Barr said. “We must bring the full force of the law against sexual predators, and with the help of our Internet Crimes Against Children program, we will. Over the span of just two months, our ICAC task forces investigated more than 18,000 complaints of internet-related abuse and helped arrest 1,700 alleged abusers. I would like to thank our Office of Justice Programs, all of the task force members, and especially the state and local partners who helped us achieve these important results. We are committed to bringing the defendants in these cases to justice and protecting every American child.”

The operation targeted suspects who: (1) produce, distribute, receive and possess child pornography; (2) engage in online enticement of children for sexual purposes; (3) engage in the sex trafficking of children; and (4) travel across state lines or to foreign countries and sexually abuse children.

The ICAC Program is funded through the Department’s Office of Juvenile Justice and Delinquency Prevention (OJJDP) within the Office of Justice Programs (OJP). In 1998, OJJDP launched the ICAC Task Force Program to help federal, state and local law enforcement agencies enhance their investigative responses to offenders who use the internet, online communication systems or computer technology to exploit children. To date, ICAC task forces have reviewed more than 922,000 complaints of child exploitation, which have resulted in the arrest of more than 95,500 individuals. In addition, since the ICAC program’s inception, more than 708,500 law enforcement officers, prosecutors and other professionals have been trained on techniques to investigate and prosecute ICAC-related cases.

For more information, visit the ICAC Task Force webpage. For state-level Operation Broken Heart results, please contact the appropriate state ICAC task force commander. Contact information for task force commanders is available online.

The Office of Justice Programs, directed by Principal Deputy Assistant Attorney General Matt M. Dummermuth, provides federal leadership, grants, training, technical assistance, and other resources to improve the nation’s capacity to prevent and reduce crime, assist victims and enhance the rule of law by strengthening the criminal justice system. More information about OJP and its components can be found at www.ojp.gov.

assisted living homes

Assisted Living in Riverside, California – www.AvenidaCareVilla.com

Compassionate, clean, professional skilled nursing for retirement aged persons.

We are a home-based facility which provides personal care assistance to persons 60 and older who are unable to safely live on their own but do not need 24-hour skilled nursing care. We also serve persons 60 and older who may want to live more independently but may need companionship. We provide 24-hour supervision & total/partial assistance with personal care – such as:

Transportation Assistance

Medication Assistance

Bedridden Services

Mental & Cognitive Stimulation

Music & Movement Activities

Activities of Daily Living (ADL’s)

Total/Partial Assistance – Personal Care


Transportation Assistance

Multiple Games & Engaging Activities

Healthy Cuisine

Housekeeping Services & more

Contact Avenida Care facility for availability!



Long-term islet transplant recipients show near-normal glucose control


Continuous glucose monitoring demonstrates improved time-in-range, key metabolic data compared to hybrid closed-loop systems

Diabetes Research Institute Foundation

Continuous glucose monitoring (CGM) evaluations in islet transplant recipients who have been insulin independent for an average of 10 years show near-normal glycemic profiles and time-in-range metrics, according to data presented by the Diabetes Research Institute at the University of Miami Miller School of Medicine. The findings, which were accepted as a late-breaking poster at the American Diabetes Association (ADA) 79th Scientific Sessions, June 7 – 11, 2019 in San Francisco, CA, demonstrate that islet transplantation can be a successful long-term cell therapy for select patients with type 1 diabetes.

The DRI team evaluated five of its adult subjects who received intrahepatic (in the liver) islet transplants between 2002 – 2010 and have since remained insulin independent for seven to 16+ years. During their last study follow-up, the subjects completed a 7-day, non-blinded CGM to assess their glycemic profiles. Compared to current recommended CGM goals for adults with type 1 diabetes on a hybrid closed-loop system, all patients demonstrated improved CGM time-in-range, reduction in glucose variability, and prevention of hypoglycemia. A sampling of the results is as follows:

CGM Glucose Range CGM % Time-in-Range recommended goals for hybrid closed-loop system CGM % Time-in-Range in DRI islet transplant subjects with long-term insulin independence
70-180 ≥70 96.4
<70 ≤3 0.9
<54 ≤1 0.1

In addition, time in the more stringent glucose range of 70-140 mg/dL was 83.1%, with a mean sensor glucose (SG) value of 116 mg/dL and an average HbA1c of 5.7%. The ADA’s recommended HbA1c goal is <7% for adults with diabetes.

“Using continuous glucose monitoring, we now have the ability to accurately evaluate patients’ glucose profiles and their variability. The CGM data we have obtained from our islet transplant patients clearly demonstrates that islet transplantation can result in glucose levels that are close to those in people who do not have type 1 diabetes, even 10 years or more after undergoing the cell-replacement procedure,” said David Baidal, M.D., assistant professor of medicine and member of the DRI’s Clinical Islet Transplant Program. One of the principal investigators of the study, Dr. Baidal is presenting the results at the ADA conference.

“Although not all subjects remain insulin independent, like the subjects described in this presentation, after an islet transplant a significant number of them continue with excellent graft function for over 10 years that allows them to have near-normal glucose metabolism in the absence of severe hypoglycemia on small doses of insulin,” said Rodolfo Alejandro, M.D., director of the Clinical Cell Transplant Program and also a principal investigator of the study. Dr. Alejandro will be presenting these results at the upcoming 17th World Congress of the International Pancreas & Islet Transplant Association, July 2-5, 2019 in Lyon, France.

“This report confirms the superiority of transplantation of insulin-producing cells compared to insulin therapy, with glucose control results that were even better than the goals of CGM in hybrid closed-loop systems. Hopefully, this will be of assistance in bringing islet transplantation closer to FDA approval, allowing the treatment to be made available to U.S. patients, as has already been the case in several other countries, for many years,” said Camillo Ricordi, M.D., Stacy Joy Goodman Professor of Surgery and director of the Diabetes Research Institute, who was recently named the world’s leading expert in islet transplantation by Expertscape. Dr. Ricordi is well-known for inventing the machine (Ricordi Chamber) that made it possible to isolate large numbers of islet cells from the human pancreas and for performing the first series of successful clinical islet transplants that reversed diabetes after implantation of donor purified islets into the liver of recipients with diabetes.

In type 1 diabetes, the insulin-producing islets cells of the pancreas have been mistakenly destroyed by the immune system, requiring patients to manage their blood sugar levels through a daily regimen of insulin therapy. Islet transplantation has allowed some patients to live without the need for insulin injections after receiving a transplant of donor cells. Some patients who have received islet transplants have been insulin independent for more than a decade, as DRI researchers have published. Currently, islet transplantation remains an experimental procedure limited to a select group of adult patients with type 1 diabetes.

In 2016, the National Institutes of Health-sponsored Clinical Islet Transplantation Consortium reported results from its Food and Drug Administration (FDA)-authorized Phase 3 multi-center trial, of which the DRI was a part, indicating that islet transplantation was effective in preventing severe hypoglycemia (low blood sugar levels), a particularly feared complication in type 1 diabetes that can lead to seizures, loss of consciousness and even death. The study was a significant step toward making islet transplantation an approved treatment for people with type 1 diabetes and reimbursable through health insurance, as it is in several other countries around the world.


About the Diabetes Research Institute

The Diabetes Research Institute at the University of Miami Miller School of Medicine leads the world in cure-focused research. As one of the largest and most comprehensive research centers dedicated to curing diabetes, the DRI is aggressively working to develop a biological cure by restoring natural insulin production and normalizing blood sugar levels without imposing other risks. Researchers have already shown that transplanted islet cells allow patients to live without the need for insulin therapy. Some study participants have maintained insulin independence for more than 10 years. The DRI is now building upon these promising outcomes through its BioHub strategy, a multidisciplinary, three-pronged approach for addressing the major challenges that stand in the way of a cure: eliminate the need for anti-rejection drugs, reset the immune system to block autoimmunity, and develop an unlimited supply of insulin-producing cells. For more information, please visit DiabetesResearch.org, call 800-321-3437, or Tweet @Diabetes_DRI.

Church & AP announce their biggest New Zealand tour yet

Fresh from the release of their compelling new track ‘Dandelion’, ‘Ready or Not’ rappers Church & AP announce their biggest New Zealand tour yet.

The tour sees Church & AP stepping up to bigger venues, giving more fans the chance to hear the best of the prolific partnership’s releases to date and experience their new music live on stage. Tickets go on sale at 9am on Tuesday 11 June.

The duo have recorded most of their debut album already, and will be heading back in to Red Bull Music Studios Auckland to wrap up the project ahead of release later this year.

“We’re used to working with nothing,” says Church.

“So having these resources at Red Bull has allowed us to operate at a new capacity. We’re not wasting any time.”

With their first international headline show taking place in London on 17 June, and ‘Dandelion’ finding favour with tastemakers and playlist makers, Church & AP are ready to show music fans why they’re the most exciting act in New Zealand hip hop.

Get in quick, you don’t want to miss out on the chance to see Church & AP before they get massive.



Moda Culta Launches Loaded International Fashion Jobs Board


Moda Culta Launches Loaded International Fashion Jobs Board

SHERIDAN, WY (June 9, 2019) – Fashion Industry professionals looking to expand the borders of their career now have a new resource to help them find the fashion jobs worldwide following the launch of International Fashion Jobs Board, Moda Culta. (Fashion News)

Boasting approximately 1000 jobs listed over a thirty-day period, Moda Culta features some fashion jobs in in Australia, UK, New Delhi, Canada, The United Arab Emirates and America. Moda Culta partnered with top recruiters in the fashion industry such as Who in the Zoo, CLIMB Retail Recruitment, Michael Page, and Office Angels to advertise the best fashion jobs.

Some of the fashion industry jobs currently listed on the job board are for Fashion Designers, Fashion Consultants, Fashion Associates, Fashion E-commerce Photographers and Fashion Instructors. Macy’s, Walmart, Everything Five Pounds are just a few of the top brands looking to fill vacancies for fashion industry jobs.

Moda Culta is a cultured fashion blog that provides the scoop on the latest fashion trends, videos, fashion news and shopping tips. (Fashion Magazine) The website also provides insight on how to make a career in the fashion industry. The blog and international fashion job board was founded by Waitman Gobble, a veteran in apparel manufacturing boasting more than 20 years’ experience in the industry. When asked about his motivation for creating the job board, Gobble explained: “I wanted to create a source for people who focus on fashion in their careers.”

The Moda Culta International Fashion Job board is easy to use. Job seekers can easily apply for any job they are interested in on the website or directly from the employer’s website. Moreover, new jobs are added daily, so the opportunities are limitless. For further information or to browse the vacancies on the Moda Culta, visit: https://modaculta.com/jobs.

Media contact: Waitman Gobble
Arduent Centisi LLC
Email: wago@culta.xyz

Waitman Gobble
Arduent Centisi LLC
+1 307-217-5609
email us here
Visit us on social media:

Daniel Marshall Brings Inaugural Modern Day Campfire to Graz, Austria – Arnold Schwarzenegger

Daniel Marshall Brings Inaugural Modern Day Campfire to Graz, Austria


DM Campfire Burns Hot in Graz, Austria – Childhood Home of Arnold Schwarzenegger


Los Angeles, CA (June 7, 2019) – Graz, Austria had its first DM Cigar Night. Hollywood cigar guru Daniel Marshall brought the Daniel Marshall Campfire cigar event to Graz, Austria, the childhood home of Governor Arnold Schwarzenegger. The Schwarzenegger Home, now a museum has rare Daniel Marshall Humidors and Cigars on display. The Graz star-studded event was hosted by Austrian real estate company, C & P Immobilien AG. Campfire events have been held worldwide from Beverly Hills to Berlin, Kitzbuhel, Austria and Shanghai.


Over 120 guests were in attendance including action star and former competitive bodybuilder Ralf Moeller, Olympic alpine medalist Hans Knauss, and No. 1 Austrian singer Andreas Gabalier. Those who attended the prestigious event enjoyed highly coveted Daniel Marshall cigars including the Golden Cigar and the Cigar Aficionado 92pt rated DM Red Label Robusto. Daniel Marshall’s Golden Cigar is the official gold cigar and is personally hand-rolled by Daniel Marshall with pure 24kt Florentine gold leaves. It is often hailed as one of the top celebratory cigars to create life’s most notable golden moments.


The Daniel Marshall Campfire event was celebrated by customers and friends of the hosts as they packed the rooftop terrace of C & P Immobilien AG’s Graz headquarters. DM cigars were eloquently paired with Padre Azul Tequila and Styrian white wine from the Golden Hill Chalets. The host Austrian real estate company was recently awarded the Fiabci Prix d’Excellence for the “Office” category. The award honors nationwide real estate projects with outstanding overall concepts. The “Oscar of the real estate industry” was awarded to the company recognizing their location as an outstanding Austrian real estate projects with innovative character and economic sustainability.



View Austria’s ORF Steiermark STEIRERBLICKE on the Daniel Marshall Modern Day Campfire Cigar Night in Graz Austria:

ORF Link 1



ORF Link 2


Video recap of the Graz Campfire:

2019 Graz Austria Campfire


To reserve your seat at the next exclusive “campfire” email: thecampfire@danielmarshall.com


For a look into Daniel Marshall Modern Day Campfire Experiences around the world visit:


Kitzbuhel Austria: 2019 Kitzbuhel Daniel Marshall Campfire

Potsdam, Germany: 2019 Potsdam Daniel Marshall Campfire

Beverly Hills: 2019 Beverly Hills Campfire


About Daniel Marshall:

Daniel Marshall, a 37-year veteran of the cigar industry is one of the leading names in the cigar world. He is top-rated Humidor designer and creator of the coveted 24kt Golden Cigar. DM Humidors & Cigars are enjoyed in the homes and offices of countless Hollywood celebrities, US presidents, dignitaries, titans of industry, fashion designers and the most discriminating cigar lovers worldwide. Marshall is also a cigar and humidor supplier of England’s Royal Family. Since 1982, Daniel Marshall has created and designed for the prestigious luxury gift houses Dunhill, Tiffany & Co., S.T. DuPont, Cartier, Hermes, Fred Joaillier, Harrod’s, Bally of Switzerland and Garrard’s of London. Daniel Marshall’s humidors are historic, with a collection on display at the Smithsonian Museum. One of DM’s highly collectible Governor Schwarzenegger Humidor’s broke sales records in 2016 at Leonardo DiCaprio’s Foundation Gala Fundraiser in St. Tropez. This extremely rare humidor topped the charts for highest amount paid for a modern day humidor with new world DM Cigars. In September 2017, a 1 of 1 humidor DM made for Prince Albert II of Monaco with Daniel Marshall Cigars was put on the block and raised 75,000 Euros to benefit our global oceans.

Visit Daniel Marshall’s site at www.danielmarshall.com. You can also find Daniel Marshall on Facebook at www.facebook.com/danielmarshallhumidorsandcigars or follow Daniel Marshall on Twitter @DMCigarWorld or Instagram @DMCigars for real-time updates.

For Daniel Marshall:

Trang Trinh, 714-973-8660, info@danielmarshall.com



Soliqua®Phase 3 results significantly lowered blood sugar levels compared to GLP-1 receptor agonist treatments

Soliqua®Phase 3 results significantly lowered blood sugarlevels compared to GLP-1 receptor agonist treatmentsPatients switched to Soliqua reached anaverage blood sugarbelowthe American Diabetes Association recommendedlevel of 7%FullPhase 3 data presentedtodayat the American Diabetes Association(ADA)79th Scientific Sessions PARIS–June 9, 2019–In a Phase 3 study1evaluating adults with type 2 diabetes inadequately controlled by GLP-1 receptor agonist (GLP-1 RA) treatments, Soliqua®/Suliqua®2(insulin glargine 100 Units/mL and lixisenatide) met the primary study objectivebydemonstrating astatistically superior reduction of average blood sugar level (HbA1c)after26weeks, compared with continuing GLP-1 RA treatment.The LixiLan-G study included either a daily or once-weekly GLP-1 RA treatmentas comparator. Morepatientswho switched to Soliqua achieved HbA1clevelsbelow 7%, a target recommended by the ADA, compared with those who stayed on previous GLP-1 RA therapy. More patients who switched to Soliqua also achieved the composite endpoint of HbA1cbelow 7% without documented symptomatichypoglycemia(low blood sugar levels).The study showed a safety profile consistent with the established profiles of the treatments studied: the most common classes of adverse event were gastrointestinal events (i.e., nausea, diarrhea and or vomiting) and hypoglycemia.1Blonde L et al, Presentation #149 OR, American Diabetes Association 79th Scientific Sessions, June 9, San Francisco, CA, U.S.2Soliqua®is an injectable prescription medicine that contains two diabetes medicines, insulin glargine and lixisenatide.Soliqua®is marketed in the EU as Suliqua®, where it is indicated in combination with metformin for the treatment of adults with type 2 diabetesmellitus to improve glycemic control when this has not been provided by metformin alone ormetformin combined with another oral glucose lowering medicinal product or with basal insulin. It is marketed in the U.S. as Soliqua®100/33, where it is indicatedas an adjunct to diet and exercise to improve glycemiccontrol in adults with type 2 diabetes mellitus.It is marketedas Soliqua®in other geographies where it is approved

The full Phase 3 data results were presented today for the first time as an oral presentation at the 79thScientific Sessions of theADAin San Francisco.“We are committed to providing people living with diabetes a broad range of options thatcan help support personalized care,”said Rachele Berria, Global Head of Diabetes Medical Affairs at Sanofi. “As the first comparison between Soliqua and both daily and weekly GLP-1 RA treatments, this study provides physicians with new data that they could use when consideringSoliqua as a part of a personalizedtreatment plan.”About the studyThe LixiLan-G study included 514 adults with type 2 diabetes who were inadequately controlled on a GLP-1 RA (either once-daily liraglutide or twice-daily exenatide, or once-weekly exenatide extended release, albiglutide or dulaglutide) and metformin (with or without pioglitazone, with or without a sodium-glucose transport protein 2 inhibitor [SGLT2i]).Participants were randomized to either switch to Soliqua or continue theirprevious GLP-1 RA treatment, while maintaining their other pre-trial anti-diabetic medication. Adherence to allocated treatment was monitored and reinforced throughout the study.The primary objective was to demonstrate superior reduction of HbA1cwith Soliqua versus continuation ofthe previousGLP-1 RA after 26 weeks. Secondary objectivesincludedcomparison of the overall efficacy and safety ofSoliqua to continued GLP-1 RA treatment. After 26 weeks, patients who switched to Soliqua saw a 0.6% greater reduction in HbA1cversus continuing treatment with a GLP-1RA:SoliquaGLP-1 RAMean HbA1cat baseline7.86%7.88%Mean HbA1cat Week 266.7%7.4%Reduction in HbA1c-1.02%-0.38%Least squares mean difference-0.64%95% Confidence interval-0.77to -0.51p-value<0.0001More patients who switched to Soliqua achieved HbA1cbelow the 7%target recommended by the ADAversus those treated with GLP-1RA(difference: 36%, p<0.0001).The study also evaluated compositetargets

of HbA1cbelow 7% without documented symptomatic hypoglycemia(<54mg/dL or ≤70mg/dL, respectively):SoliquaGLP-1 RA% of patientsachieving HbA1c< 7%62%26%% of patients achieving HbA1c<7% with no documented (≤70 mg/dL) symptomatic hypoglycemia43%25%% of patients achieving HbA1c<7% with no documented(<54 mg/dL) symptomatic hypoglycemia57%25%The study showed a safety profile consistent with previous studies:22% of patients who switched to Soliqua experienced gastrointestinal events (nausea, diarrheaor vomiting), compared with 10% of patients who continued previoustreatment with GLP-1 RA. Rates of hypoglycemiawere also consistent with the established safety profiles of thetreatments: 9% of patients who treated with Soliqua experienced at least one event, compared with <1% who remained on previous GLP-1 RA therapy.Participants treated with Soliqua were followed for a further 26 weeks. Data from this extension period will be presented at a later date.About SanofiSanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.Sanofi, Empowering LifeMedia Relations ContactAshleigh KossTel.: +1 908-981-8745Ashleigh.Koss@sanofi.comInvestor Relations ContactGeorge GrofikTel.: +33 (0)1 53 77 45 45ir@sanofi.comSanofi Forward-Looking StatementsThis press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates regarding the marketing and other potential of the product, or regarding potential future revenues from the product. Forward-looking statements are generally identified by the words “expects”, “anticipates”, “believes”, “intends”, “estimates”, “plans” and similar expressions. Although Sanofi’s management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actualresults and developments to differ materially fromthose expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, unexpected regulatory actions or delays, or

government regulation generally, that could affect the availability or commercial potential of the product, the absence of guarantee that the product will be commercially successful, the uncertainties inherent in research and development, includingfuture clinical data and analysis of existing clinical data relating to the product, including post marketing, unexpected safety, quality or manufacturing issues, competition in general, risks associated with intellectual property and any related future litigation and the ultimate outcome of such litigation, and volatile economic conditions, as well as those risks discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Statements” in Sanofi’s annual report on Form 20-F for the year ended December 31, 2018. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise anyforward-looking information or statements.

PRESS RELEASE: Life Science Institute

For Immediate Release:
For More Information Contact: Gary Ruskin +1 415 944-7350 or Sarah Steele +44 7768653130

The nonprofit International Life Science Institute claims to conduct “science for the public good” that “improves human health and well-being and safeguards the environment,” but really is a food industry lobby group, according to a study published today in the journal Globalization and Health.

The study provides examples of how ILSI advances the interests of the food industry, especially by promoting industry-friendly science and arguments to policymakers. The study is based on documents obtained via state freedom of information requests by U.S. Right to Know, a nonprofit investigative research group focused on the food industry.

The study’s authors conclude that, “ILSI should be regarded as a lobby group and that academics and researchers, policy makers, the media, and the public should view ILSI’s research as promoting the interests of the food, beverage, supplement and agrichemical industries” and that its actions “counter healthy public policies.”

“ILSI is Big Food’s global stealth network to defeat scientists, regulators and others who point out the health risks of their products,” said Gary Ruskin, co-director of U.S. Right to Know. “Big Food wants you to believe that ILSI works for your health, but really it defends food industry profits.”

The Globalization and Health paper was co-authored by Sarah Steele, senior research associate at Jesus College and the University of Cambridge; Gary Ruskin, co-director of U.S. Right to Know; Lejla Sarcevic, Intellectual Forum senior research associate at Jesus College, Cambridge; Martin McKee, professor at the London School of Hygiene & Tropical Medicine; and, David Stuckler, professor at Bocconi University.

In January, two papers by Harvard Professor Susan Greenhalgh, in the BMJ and the Journal of Public Health Policy, revealed ILSI’s powerful influence on the Chinese government regarding issues related to obesity.

ILSI is incorporated as a 501(c)(3) nonprofit organization, based in Washington DC.  It was founded in 1978 by Alex Malaspina, a former senior vice president of Coca-Cola. It has 17 branches located all over the world.

As an example of how ILSI keeps in close alignment with Coca-Cola and the soda industry, the paper quotes an email from Malaspina in which he laments ILSI Mexico’s failure to follow the industry position on soda taxes. Malaspina describes “the mess ILSI Mexico is in because they sponsored in September a sweeteners conference when the subject of soft drinks taxation was discussed. ILSI is now suspending ILSI Mexico, until they correct their ways. A real mess.”

“Our findings only continue to add to the evidence that this non-profit organisation has been used by its corporate backers for years to counter public health policies. We contend that the International Life Sciences Institute should be regarded as an industry group – a private body – and regulated as such, not as a body acting for the greater good,” said the study lead author Dr. Sarah Steele, a researcher at Cambridge’s Department of Politics and International Studies.

Documents from the ILSI study will be posted in University of California, San Francisco’s Food Industry Documents Archive, in the U.S. Right to Know Food Industry Collection.

For more information about U.S. Right to Know, see our academic papers at https://usrtk.org/academic-work/. For more general information, see usrtk.org.


2nd June, 2019



Accra, Sunday June 2, 2019…In line with ongoing reforms by Government at the Ghana Revenue Authority (GRA) to improve performance, consistent with the 2019 Budget (paragraph 288), there have been changes at the Top Management level of the institution. Also, about one thousand four hundred and eighteen (1,418) employees are being rotated to other areas of the organisation. Further changes will be made to retool GRA for the critical task of mobilizing revenue to finance improvements in the lives of our people.

The reorganisation has been necessitated by three (3) main factors:
First, the Institution has grown significantly over the years, and current revenues of approximately GH¢38 billion make it one of the biggest Institutions in Ghana. This has created the need for much stronger, world-class structures.
Secondly, the number of employees of the GRA has increased significantly to about 7,000 and another 5,000 have been added through NABCO to shore up the authority’s revenue mobilization capacity, bringing the total employees to 12,000. GRA is now one of the largest employers outside the Civil Service.
Thirdly, there has been increasing need for better domestic revenue mobilization in order to realise the Ghana Beyond Aid agenda. With Ghana’s
Revenue to GDP of 12.6%, below the West Africa average of 19.9%, there is the need to raise domestic revenue in a more efficient way in order to meet the country’s commitments. GRA revenues have failed to reach budget targets, and over the last three years there has been an accumulated gap of about GH¢3.5 billion.

Given all of the above factors, it has become necessary to make changes to the Management and organisational structure to make it a much better performing institution.

These changes are expected to bring several improvements in the institution. This includes bringing the best of private sector practices and combining that with public sector technical expertise to ensure that GRA is a better functioning institution. Additionally, these changes are expected to improve the overall level of professionalism and engender a customer-friendly mindset at GRA.

In line with expectations, the new team will be expected to drive a number of critical transformational changes:

Modernising and digitising tax processes and systems;

Introducing big data and block chain technologies to improve compliance;

Expanding the tax base to encompass more effectively the informal sector and professional classes (currently there are over 6 million eligible tax paying individuals, however, only about 2.5 million have been registered and only about 1.2 million are active direct tax payers); and

Developing a stronger culture of performance and accountability;

Enhancing staff integrity and anticorruption measures;

Increasing the quality of tax payer services;

Respecting the client (taxpayer);

Creating a fair and firm tax organisation that ensures equitable treatment of every tax payer;

Tackling revenue leakages across both Domestic Tax and Customs;

Ensuring that best practices are shared, to create a truly world-class organisation.

To drive this transformation, changes have been made at various levels across the entire organisation involving about one thousand four hundred and eighteen (1,418) employees who are being rotated to other areas of the Institution. At the leadership level, the following new appointments have been made:

Mr. Ammishaddai Owusu-Amoah Acting Commissioner for Domestic Tax Revenue Division

Colonel Kwadwo Damoah (Rtd), Acting Commissioner, Customs Division

Ms. Julie Essiam, Acting Commissioner, Support Services Division

We take this opportunity to thank the current leadership team at GRA who have brought GRA thus far. We wish the Commissioner-General and his new team success as they take the reins to lead GRA to the next level. END




PRESS RELEASE: DSH Program Essential for Iowa’s Hospitals

For Immediate Release: May 23, 2019

Contact: Matt Sinovic, (515) 423-0133

In Case You Missed It:

DSH Program Essential for Iowa’s Hospitals

Des Moines, Iowa – Last week, 302 members of the House of Representatives sent a  bipartisan letter to Congressional leaders calling for a delay in cuts to the Medicaid Disproportionate Share Hospital (DSH) program. Three of Iowa’s four representatives, including Democrats and Republicans, signed the letter.

The Medicaid DSH program provides vital support to Iowa hospitals that serve a disproportionate number of Medicaid beneficiaries and uninsured patients. The DSH program is essential to ensuring that such hospitals can continue to serve low-income patients who don’t have private insurance.

“In treating those who have nowhere else to turn, these hospitals incur uncompensated costs…Medicaid DSH payments allow them to continue serving our constituents and communities,” the letter reads.

According to the Medicaid and CHIP Payment and Access Commission (MACPAC), if the cuts are implemented, Iowa hospitals could lose $6.6 million the first year and double that number the following year. Industry experts warn that the proposed cuts to the program are unsustainable for struggling safety net hospitals, especially in rural areas, and could force some of them to reduce services or even close their doors.

The full letter can be read here.

Signees include:

  • Rep. Abby Finkenauer
  • (D, IA-01)
  • Rep. Cindy Axne (D,
  • IA-03)
  • Rep. Steve King (R,
  • IA-04)

PRESS RELEASE: Positive New Data with Multi-Cancer Early Detection Blood Test from CCGA Study

GRAIL Announces Positive New Data with Multi-Cancer Early Detection Blood Test from CCGA Study

— Investigational Multi-Cancer Blood Test Detects Strong Signal for 12 Deadly Cancer Types When They are Still Localized, with 99 Percent Specificity, and Identifies Tumor’s Tissue of Origin with High Accuracy —

— Data Presented at 2019 ASCO Annual Meeting Support Feasibility of GRAIL’s Multi-Cancer Approach — 

— GRAIL Plans to Advance Development of Multi-Cancer Test Toward Commercialization —  

MENLO PARK, Calif., May 31, 2019–GRAIL, Inc., a healthcare company focused on the early detection of cancer, today announced new data from the Circulating Cell-free Genome Atlas (CCGA) study that demonstrates the ability of GRAIL’s technology to detect cancer early with a single blood test. Data showed GRAIL’s investigational multi-cancer blood test detected a strong signal for 12 deadly cancer types at early stages with a very high specificity of at least 99 percent (or a false positive rate of one percent or less). In addition, the test identified where the cancer originated in the body (the tissue of origin) with high accuracy.

Detection rates (sensitivity) for the 12 deadly cancer types ranged from 59 to 86 percent at early stages (stages I-III). A combined analysis of this group of cancers showed robust detection at early stages (34 percent, 77 percent, and 84 percent at stages I, II, and III, respectively). In addition, a tissue of origin result was provided for 94 percent of all cancers detected and, of these, the test correctly identified the tissue of origin in 90 percent of cases.

The 12 pre-specified cancer types included anorectal, colorectal, esophageal, gastric, head and neck, hormone receptor negative breast, liver, lung, ovarian, and pancreatic cancers, as well as multiple myeloma and lymphoid neoplasms. Together, these cancer types account for approximately 63 percent of all cancer deaths in the United States.

These data will be presented in a poster tomorrow, Saturday, June 1 at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting by Minetta Liu, MD, Research Chair and Professor, Department of Oncology, Mayo Clinic (Abstract 3049).

“These exciting results suggest we can achieve what we believe are the requirements for a cancer screening blood test, including detection of multiple deadly cancer types at early stages in a single test, high accuracy in determining where the cancer originated, and a very low false positive rate,” said Jennifer Cook, Chief Executive Officer at GRAIL. “Our improved methylation-based technology has the potential to address gaps that exist with today’s screening options, which are limited to a few cancer types and only screen for one cancer type at a time. Based on these positive data, we plan to advance development of our test toward commercialization.”

“These very promising data indicate that a highly specific blood test for early cancer detection is approaching reality,” said Dr. Liu, who is also an investigator on the CCGA study. “The exceptional accuracy in determining the tissue of origin across all stages for those malignancies with significant cancer-specific mortality suggests that, if a cancer is detected, the test will inform where the tumor originated in the majority of cases. This factor is critical to streamline the clinical workup.”

“When we set out on this journey, we knew that to be successful, a blood-based screening tool would need to detect the clinically important cancers and not contribute to overdiagnosis of indolent cancers at the earliest stages,” said Rick Klausner, MD, Former Director of the National Cancer Institute, and Founder and Director of GRAIL. “Data being presented at ASCO suggest GRAIL’s test preferentially detects the most lethal cancers and can detect tumors when they are still localized and amenable to successful treatment. The high detection rate of stage II cancers at 77 percent in the group of 12 deadly cancers is particularly compelling and supports the potential benefit of our multi-cancer approach.”

Additional Results

In the second pre-planned case-control sub-study of CCGA, GRAIL’s multi-cancer early detection blood test is being evaluated in approximately 4,500 participants for its ability to detect cancer and identify the tissue of origin when cancer is present. Data reported at ASCO are based on an initial analysis of 2,301 participants from the training phase of the sub-study, including 1,422 participants with more than 20 cancer types across all stages and 879 participants without diagnosed cancer. This sub-study is ongoing, and the company is planning to present additional results at future medical conferences.

All results are reported at 99 percent specificity, which equates to a false positive rate of one percent. The actual false positive rate may be less than one percent, since cancer incidence rates suggest some of the individuals enrolled in the non-cancer group may have had an undiagnosed cancer at enrollment. Follow-up of participants in CCGA is ongoing, and outcomes will be collected for five years.

The overall detection rate for more than 20 cancer types in the sub-study across all stages was 55 percent (n=784/1,422; 95% confidence interval: 52.5-57.7%). A tissue of origin result across more than 20 cancer types was provided for 94 percent of all cancers detected by GRAIL’s test (n=735/784), and of these, the test correctly identified the tissue of origin in 90 percent of cases (n=663/735).

The overall detection rate for the 12 pre-specified deadly cancer types across all stages was 76 percent (n=671/882; 95% confidence interval: 73-79%). The tissue of origin accuracy for this group of cancers was consistent regardless of stage ranging from 84 to 92 percent.

Additional results for the 12 pre-specified deadly cancer types are detailed below.

Detection Rates (Sensitivity) at Early Stages (Stages I-III) for 12 Deadly Cancer Types at 99 Percent Specificity

Cancer Type (N) Sensitivity
(95% CI)
Lung (151) 59%
Colorectal (72) 74%
Hormone Receptor Negative Breast (67) 64%
Lymphoma (60) 70%
Pancreatic (41) 78%
Head and Neck (36) 86%
Multiple Myeloma (34) 71%
Ovarian (30) 67%
Esophageal (25) 76%
Liver (25) 68%
Anorectal (14) 79%
Gastric (9) 78%

Excludes leukemias, which are not staged

Detection Rates (Sensitivity) and Tissue of Origin Accuracy by Stage for 12 Deadly Cancer Types at 99 Percent Specificity

Stage Sensitivity
(95% CI)
Tissue of Origin Accuracy*
Stage I 34%
Stage II 77%
Stage III 84%
Stage IV 92%

Excludes leukemias, which are not staged
*Performance in 94% of cases where a tissue of origin result was provided 

Tissue of Origin Prediction Across All Stages (Stages I-IV) for 12 Deadly Cancer Types at 99 Percent Specificity*

Cancer Type
(Number of Predictions)
Correct Tissue of Origin
Lung (165) 92%
Colorectal (87) 97%
Breast (78) 96%
Lymphoid Neoplasms (107) 89%
Pancreatic (68) 79%
Head and Neck (53) 81%
Multiple Myeloma (23) 96%
Ovarian (25) 96%
Upper Gastrointestinal (Esophageal and Gastric combined) (44) 89%
Liver (29) 72%
Anorectal (3) 67%

*Performance in 94% of cases where a tissue of origin result was provided

Poster Presentation Details

Posters will be available online at https://grail.com/science/publications/ at time of presentation.

Abstract 3049*
Minetta C. Liu, et al. Genome-wide cell-free DNA (cfDNA) methylation signatures and effect on tissue of origin (TOO) performance
Poster Session: June 1, 2019: 8:00-11:00AM CDT, Hall A, Poster Board #41
*Includes data from second CCGA sub-study

Abstract 3103
Darya Filippova, et al. The Circulating Cell-free Genome Atlas (CCGA) study: Size selection of cell-free DNA (cfDNA) fragments
Poster Session: June 1, 2019: 8:00-11:00AM CDT, Hall A, Poster Board #95

Abstract 5574
Allen Cohn, et al. The Circulating Cell-free Genome Atlas (CCGA) study: Follow-up (F/U) on non-cancer participants with cancer-like cell-free DNA signals
Poster Session: June 1, 2019: 1:15-4:15PM CDT, Hall A, Poster Board #397

Abstract 1545
Geoffrey R. Oxnard, et al. Prognostic significance of blood-based cancer detection in plasma cell-free DNA (cfDNA): Evaluating risk of overdiagnosis
Poster Session: June 3, 2019: 1:15-4:15PM CDT, Hall A, Poster Board #39

About CCGA

The Circulating Cell-free Genome Atlas (CCGA) study is a prospective, observational, longitudinal, case-control study that has completed enrollment of approximately 15,000 participants with and without cancer across 142 sites in the United States and Canada. CCGA is designed to characterize the landscape of genomic cancer signals in the blood and to discover, train, and validate GRAIL’s multi-cancer early detection blood test through three pre-planned sub-studies.

About GRAIL’s Investigational Multi-Cancer Early Detection Test

GRAIL is developing a next-generation sequencing (NGS) blood test for the early detection of multiple deadly cancer types. GRAIL’s high efficiency methylation-based technology preferentially targets the most informative regions of the genome and is designed to use its proprietary database and machine-learning algorithms to both detect the presence of cancer and identify the tumor’s tissue of origin. GRAIL’s sequencing database of cancer and non-cancer methylation signatures is believed to be the largest of its kind and covers approximately 30 million methylation sites across the genome. More than 20 cancer types across stages are represented within the database.

DNA methylation is a natural process used by cells to regulate gene expression. It is a chemical modification to DNA and a well-studied epigenomic feature of the genome. In cancer, abnormal methylation patterns and the resulting changes in gene expression can contribute to tumor growth. For example, hypermethylation can cause tumor-suppressor genes to be inactivated.


GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by developing pioneering technology to detect and identify multiple deadly cancer types early. The company is using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art computer science and data science to enhance the scientific understanding of cancer biology, and to develop its multi-cancer early detection blood test. GRAIL is located in Menlo Park, California. It is supported by leading global investors and pharmaceutical, technology, and healthcare companies. For more information, please visit www.grail.com.


Charlotte Arnold


PRESS RELEASE: MTA Launches Public Pilot For OMNY Contactless Fare Payment System – First New Payment System In 25 Years

MTA Launches Public Pilot For OMNY Contactless Fare Payment System – First New Payment System In 25 Years
Sixteen Stations Along Lexington Avenue 56 Line and All MTA Staten Island Buses Now Equipped With OMNY 
MetroCard To Remain Until 2023 As MTA Rolls Out to OMNY to Rest Of System by February 2021
OMNY Will Save Customers’ Time and Provide More Payment Choices – Avoiding Lines at MetroCard Vending Machines, Alleviating Crowding, Speeding Buses, And Reducing MTA Costs


The MTA today announced the launch of OMNY, its new contactless fare payment system, allowing riders to pay their fares with digital wallets and contactless credit and debit cards.  The public pilot was kicked off at a public event this afternoon at the Bowling Green station in Lower Manhattan.

MTA executives marked the beginning of the gradual rollout of OMNY by joining several students from Transit Tech High School as well as leaders from Cubic Transportation Systems, wich is helping build OMNY, for a demonstration of the new system on the lower mezzanine of the Bowling Green Station.

OMNY is a first-of-its-kind system that lets riders pay their fare and enter the subway or bus by simply tapping contactless credit, debit, and reloadable prepaid cards, mobile phones, smart watches, and other wearable devices. OMNY will eventually provide a seamless payment system across the MTA’s subways, buses, and two commuter railroads.

OMNY is the first transit agency that will launch with an open loop contactless payment system, meaning customers never need to wait in line to buy a fare card. They simply use the device of their choice and seamlessly enter the system. In time, OMNY will allow customers to pay their fares on subways, buses and the two commuter rails using the same payment method.

“Today marks a huge step on a journey to bring our fare payment system into the modern era, allowing for a better customer experience for millions of MTA riders and employees,” said MTA Chairman and CEO Patrick Foye.  “The MTA team responsible for getting this critical project off the ground deserves a huge thank you from all New Yorkers. As of today, completion of Phase One of OMNY is on budget, and on schedule.”

“The significance of moving to a modern fare payment system cannot be overstated,” said New York City Transit President Andy Byford. “Eventually, OMNY will help ease congestion in the system, reduce a host of technical challenges associated with the MetroCard, and make our system easier and more intuitive for the tens of millions of New Yorkers and tourists who ride with the MTA each year. I’m eager to continue rolling out this easy-to-use technology to all remaining subway stations and bus routes in the next 18 months.”

“In the more than three decades that I’ve worked here to improve processing customer payments, from tokens to MetroCards, I can truly say that OMNY will be transformative for our customers as well as our organization,” said Alan Putre, OMNY Program Executive. “Our customers can pay for transit the same way they pay for any other products or services now. The technology will allow us to serve our customers in new and better ways, while continuing to provide travel access and support all of our special fare program customers.”

The public pilot phase of the OMNY rollout, which runs through the end of 2019, will allow the MTA to ensure that all systems are fully functional and that any issues are identified and improved upon prior to continuing the rollout of OMNY readers to the rest of the system.

Completion of the entire OMNY project in 2023 will empower customers to choose how, when and where they pay for their fares.  OMNY will provide more robust customer service, including a new OMNY app which will provide seamless fare payment between the Long Island Rail Road and Metro-North services and subway and bus services, as well as the introduction of the OMNY card to support customers who prefer to fund fares with cash. Eventually, the system will accommodate the migration of all current unlimited ride pass and other special fare products over to the OMNY environment and the option to purchase fare products online or in stations and new machines A closed-loop OMNY card will be sold in stations at a robust network of retail stores beginning in 2021, so cash will always be an option.

During the MTA’s rollout of the OMNY contactless readers and continued expansion of OMNY services between 2019 and 2023, riders can still use MetroCard and eTix.

The public pilot phase of the rollout brings OMNY contactless payments to all Staten Island MTA buses and at all subway station entrances on the 456 lines between Grand Central-42 St and Atlantic Av-Barclays Ctr. Initially, OMNY will support a full-fare, pay-per-ride option until all subway stations and bus routes are equipped with the new technology. Customers have the ability to access their trip history by registering for an OMNY account at omny.info.

“Cubic has enjoyed a long and strong partnership with the MTA and today we’re pleased to see New York taking the first major step towards a fully operational mobile-enabled and contactless fare payment system leveraging our technologies,” said Matt Cole, president of Cubic Transportation Systems. “We’re excited to see New Yorkers begin to use the new technology that will simplify their journeys and make their payment experience seamless.”

All remaining bus routes, subway stations, and Staten Island Railway locations will be equipped by late 2020. OMNY is expected to be enabled for LIRR and Metro-North Railroad by early 2021. Between 2021 and 2023, the MTA will support all remaining fare options, introduce the OMNY Card in retail locations throughout the New York region, and install new vending machines at locations throughout the system.

Only after the OMNY project is fully complete in 2023 will the MTA say goodbye to MetroCard for good. The MetroCard debuted in 1993.



“Consumers around the world have quickly embraced the speed, convenience and security of tapping to pay. We are excited to be working with the MTA to enable this experience for New Yorkers, helping save valuable time and giving riders an easier way to get where they need to be.”- Dan Sanford, Global Head of Contactless Payments, Visa.

“Whether it’s your vacation or your daily commute, every second counts when you are trying to get around New York City. By partnering with the MTA and Cubic, we are using our payment and security technology to enable tap and go payments and make travel in the city easy, fast and hassle-free.”-  Linda Kirkpatrick, Executive Vice President, US Merchants and Acceptance, Mastercard.

“American Express has offered contactless payment capabilities internationally for many years, and we’re thrilled to now work with the New York MTA to enable American Express Card Members to use their contactless-enabled card or digital wallet at the pilot subway stations. As contactless becomes available at more stations and businesses throughout New York, our Card Members will have the speed and convenience of being able to tap-to-pay at transit turnstiles and beyond.”- Jaromir Divilek, Executive Vice President, Global Network Operations, American Express.

“We’re proud Apple Pay is helping make New Yorkers’ daily commutes a little easier starting today. Once a customer sets up a payment card in Apple Wallet to use for Express Transit, they can simply tap their iPhone and Apple Watch on the reader to quickly go through the turnstile and ride the subway or board the bus.”- Jennifer Bailey, vice president of Internet Services, Apple.

“When Discover’s contactless technology is implemented, it will make it easier and faster for commuters in New York City to pay for rides and access public transportation. We’re looking forward to helping cities incorporate contactless payments into their mass transit systems with the goal of providing more seamless commuter experiences for their riders.”-  Ricardo Leite, vice president of global products and partnerships at Discover.

“We want to make commuting simpler for everyone and we’re working with the MTA to enable Google Pay for NYC transit. Now, you can seamlessly tap and pay with your phones and save valuable time — and you can do this easily without even having to open the app or unlock your device. Additionally, in the next few weeks, Google Maps will let you see which routes accept Google Pay when you look up directions.” — Prakash Hariramani, Director, Google Pay.

“Samsung Pay provides access to great deals, earn rewards, and use of your mobile device to pay practically anywhere you can swipe a card. Now, we are continuing the evolution by bringing even more benefits to consumers. We are excited to help bring mobile innovation to New York City Transit commuters by delivering speed, convenience, and security to millions of daily commuters who use Samsung Pay.” – Sang Ahn, Vice President and General Manager for Samsung Pay.

“We’re excited to work with the MTA, one of the most recognized transit systems in the world, to empower consumers in New York City to easily tap to pay for subway transit from their wrist. We’ve always been about helping users be healthier, but we also continue to build on the overall utility of our platform to promote an active lifestyle. With that, we currently support open and closed loop transit systems around the globe, so we can provide valuable convenience, like effortlessly using a Fitbit smartwatch or tracker to pay for the subway, so users can go about their day and focus on what’s most important to them.”- James Park, CEO and Co-Founder of Fitbit.



  • The MetroCard was first tested in the system in 1993, debuting to the larger public in January 1994. All MetroCard turnstiles were installed by May 1997 and all buses began accepting it by the end of 1995. Tokens were sold until April 2003 and were discontinued that May.
  • OMNY readers accept contactless cards from Visa, Mastercard, American Express, and eventually Discover Card as well as Apple Pay, Google Pay, Samsung Pay and Fitbit.
  • Transit Technical High School offers the city’s only vocational program that prepares high school students for careers at MTA New York City Transit. Students learn career and technical skills specifically aimed at getting them ready for NYC Transit careers. Many immediately enter apprenticeship programs at New York City Transit. More info about Transit Tech and the MTA’s longstanding relationship is available here.
  • Cubic Transportation Systems has been a partner with the MTA in helping develop the technology since the very beginning of the process and also helped develop MetroCard. Since the introduction of the MetroCard system, Cubic has continued to support the MTA through various projects, including the introduction of the Select Bus Service, Second Avenue subway, 7 line extension, creation of the Barclays Center transit hub, South Ferry Terminal, Tompkinsville Station, Fulton Street Transit Center, Westchester Bee-Line and recovery from Superstorm Sandy, among many others.